# Yi Lin

> Yi Lin is a Series A investor at ePlanet Capital (Greenwich) backing Medical and Biopharma. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [ePlanet Capital](https://shizune.co/investors/profile/dfj-eplanet-ventures)
- Location: Greenwich, United States
- Total investments: 3
- Last investment: Jan 2023
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/yi-lin-a0299326

Yi Lin is a Partner at ePlanet Capital. He attended Peking University.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 2 | 67% |
| Biopharma | 1 | 33% |
| Health Care | 1 | 33% |
| Biotechnology | 1 | 33% |
| Manufacturing | 1 | 33% |

7 industries tracked in total.

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Human Zhizao | Human Intelligent Manufacturing is a fully automatic multiple flow fluorescence platform. |  | Series A | Jan 04, 2023 |  |
| Ubiquitin Bio | Ubiquitin Bio is a research and development manufacturer of in vitro diagnostic products. |  | Series A | Nov 22, 2022 |  |
| CART Medical | CART Medical Technologies, Ltd. is a high-tech company specializing in the development and application of new technologies for immune cell therapy. It has a 2,200 square meter GMP laboratory and research and development laboratory. |  | Series A |  |  |

3 of 3 investments shown.

## About ePlanet Capital

VC Fund · San Jose, United States

EPlanet Capital is a growth investor that provides venture capital and investment for telecom, media, and technology companies.It is focused on companies that display considerably high growth and development in emerging and developing countries of the world.EPlanet Capital has invested in over 99 companies that span from Baidu in China toVirgin Mobile in Latin America.

5 contacts available at ePlanet Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Nick Yang | Venture Partner | https://shizune.co/investors/profile/nick-yang |
| Yi Lin | Partner | https://shizune.co/investors/profile/yi-lin |
| Yi Lin | Partner | https://shizune.co/investors/profile/yi-lin-3 |
| Asad Jamal | Founder & Chairman | https://shizune.co/investors/profile/asad-jamal |
| Fredrik Brag | Venture Partner | https://shizune.co/investors/profile/fredrik-brag |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Yi Lin invest in?

Yi Lin invests primarily in Medical, Biopharma and Health Care startups, most often at Series A stage. Most of the 3 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Yi Lin last invest?

The most recent investment recorded for Yi Lin closed in Jan 2023. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co